Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

The study focused on 78 participants diagnosed with major depressive disorder who also had strong suicidal thoughts ... Its ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

If you’ve been diagnosed with clinical depression, also known as major depressive disorder (MDD), rest assured there are many treatment options available. Some people will experience only one ...

Even though there are now many ways to communicate through technology, I still believe that handwritten letters remain an ...

altered appetite and sleep/wake balance. Its severe form, major depression is classified as a mood disorder.